[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366682-105":59,"doc-detail-366682-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-impact-of-systemic-inflammatory-markers-on-egfr-mutant-non-small-cell-lung-cancer-research-article","The impact of systemic inflammatory markers on EGFR-mutant non-small cell lung cancer - research article","","Background: EGFR-mutant (EGFRm) non-small cell lung cancer (NSCLC) shows high prevalence in Asian populations. Preclinical evidence suggests PM2.5–driven inflammatory cytokines may influence EGFRm clonal expansion. This study examines the association between systemic inflammatory markers and EGFRm NSCLC by comparing tumor tissues and blood serum. Methods: Resected NSCLC patients (2016–2023) provided tumor and serum samples for biomarker assays and cytokine profiling. Results: STAT3 in cancer cells and non-smoking status were associated with EGFRm NSCLC, supporting inflammation-related mechanisms.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-impact-of-systemic-inflammatory-markers-on-egfr-mutant-non-small-cell-lung-cancer-research-article/366682/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-impact-of-systemic-inflammatory-markers-on-egfr-mutant-non-small-cell-lung-cancer-research-article/366682.png","ImageObject",300,407,{"name":92,"@type":93},"Well Done","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-16","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the study investigating about EGFR-mutant NSCLC?","Question",{"text":112,"@type":113},"The study investigates how systemic inflammatory markers correlate with EGFR-mutant NSCLC, focusing on relationships between inflammatory proteins and cytokines and EGFR mutation status.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were tumor samples and EGFR mutations analyzed?",{"text":117,"@type":113},"Resected NSCLC patients (2016–2023) were enrolled, tumor tissues and blood serum were retrieved, and EGFR 19del and L858R mutations were determined using rt-PCR in cancerous tissue and dPCR in normal tissue from the same patient.",{"name":119,"@type":110,"acceptedAnswer":120},"Which inflammatory biomarker(s) were associated with EGFR-mutant NSCLC?",{"text":121,"@type":113},"In multivariable analysis, STAT3 in cancer cells, together with non-smoker status, was associated with EGFR-mutant NSCLC; the study also reports differences in signaling proteins between cancerous and normal tissues.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},366682,1790196466,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},5909892210082,"https://ap-avatar.wpscdn.com/avatar/56001069da27c9f41e8?x-image-process=image/resize,m_fixed,w_180,h_180&k=1789614185077863061","Wangsubtawee et al. BMC Cancer (2025) 25:1510 BMC Cancer  \n[https://doi.org/10.1186/s12885-025-14915-1](https://doi.org/10.1186/s12885-025-14915-1)  \nRESEARCH Open Access  \nThe impact of systemic inflammatory markers on EGFR-mutant non-small cell lung cancer  \nSupagone Wangsubtawee 1,2,3†, Thanaporn Thamrongjirapat 1,3†, NarumolTrachu4, Pimpin Incharoen5, Natini Jinawath6,7,8, Passaworn Cheyasawan5, Nanamon Monnamo4, Dittapol Munthum9,  \nNattanan Reungwetwattana 10, Salin Amponnavarat 11, Pimtip Sanvarinda 12, Arthit Chairoungdua 13, Montien Ngodngamtaweesuk3,14, Khantong Khiewngam2,11, Ekaphop Sirachainan 1,3, Phichai Chansriwong 1,3, Thitiya Dejthevaporn 1,3, Thanyanan Reungwetwattana 1,3*† and Putthapoom Lumjiaktase5*†  \nAbstract  \nBackground High prevalence of EGFRm lung cancer was found in the Asian population. Preclinical data suggest that inflammatory cytokines activated by PM2 .5 affected EGFRm clone expansion. Here, we explored the correlation between inflammatory markers and EGFRm NSCLC.  \nMethods Resected NSCLC patients (2016–2023) were enrolled. Tumor tissues and blood serum were retrieved from Ramathibodi tumor biobank. EGFR 19del and L858R mutations were performed by rt-PCR in cancerous tissue and dPCR in normal tissue in the same patient. NF-Kb and STAT3 protein signaling were measured by ELISA in both cancerous and normal tissue. Cytokines (IL-1ß, IL-6, IL-8, IL-10, IL-12 and TNF-α) were explored in serum by flow cytometry.  \nResults Among 140 patients, EGFRm prevalence was 58% in cancerous tissue but only 5% in normal tissue. NF-kBand STAT3 were statistically higher in cancerous tissue than normal tissue [NF-kB median O. D. =0 .82 (IQR; 0 .07–2. 82) vs. 0.32 (IQR; 0 .05–2.48), P \u003C 0. 001; STAT3 median O. D. =0 .32 (IQR; 0 .10–1. 58) vs. 0.17 (IQR; 0 .06–1. 29, P \u003C 0. 001] . STAT3 was significantly increased in EGFRm compared to EGFRwt [median O. D. =0 .36 (IQR; 0 .234–0. 592) vs. 0.23 (IQR; 0 .158–0.409), OR = 11.09 (95% CI; 2 .17–56. 58), P = 0 . 004] . TNF-α, IL-10, and STAT3 in cancer cells were higher in EGFRm than EGFRwt (P = 0 . 003, 0 . 008, and \u003C 0. 001, respectively) . None of cytokines was statistically different between EGFRm and EGFRwt patients. However, only STAT3 in cancer cells and non-smoker were associated with EGFRm NSCLC in multivariable analysis.  \n\n| †Supagone Wangsubtawee and Thanaporn Thamrongjirapat contributed equal works as the co-first author. |\n| --- |\n| †Putthapoom Lumjiaktase and Thanyanan Reungwetwattana contributed equal works as the co-corresponding author. |\n\n*Correspondence:  \nThanyanan Reungwetwattana [thanyanan. reu@mahidol.ac.th](thanyanan. reu@mahidol.ac.th)[ ](thanyanan. reu@mahidol.ac.th)Putthapoom Lumjiaktase [putthapoom@gmail.com](putthapoom@gmail.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icenses/by-nc-nd/4.0/.  \nWangsubtawee et al. BMC Cancer (2025) 25:1510 Page 2 of 10  \nConclusion Inflammat","cbCaioBiZbwME3uH","https://ap.wps.com/l/cbCaioBiZbwME3uH","pdf",2363579,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What is the study investigating about EGFR-mutant NSCLC?\",\"answer\":\"The study investigates how systemic inflammatory markers correlate with EGFR-mutant NSCLC, focusing on relationships between inflammatory proteins and cytokines and EGFR mutation status.\"},{\"question\":\"How were tumor samples and EGFR mutations analyzed?\",\"answer\":\"Resected NSCLC patients (2016–2023) were enrolled, tumor tissues and blood serum were retrieved, and EGFR 19del and L858R mutations were determined using rt-PCR in cancerous tissue and dPCR in normal tissue from the same patient.\"},{\"question\":\"Which inflammatory biomarker(s) were associated with EGFR-mutant NSCLC?\",\"answer\":\"In multivariable analysis, STAT3 in cancer cells, together with non-smoker status, was associated with EGFR-mutant NSCLC; the study also reports differences in signaling proteins between cancerous and normal tissues.\"}]","The impact of systemic inflammatory markers on EGFR-mutant non-small cell lung cancer - research article | PDF",1790166698,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/67807ee429e83452921988d317f09e2e.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f60e16d9e578b58a1cc60a3730e15501.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/041e46e87cf7830427b6417e8ffd518f.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f370d6cfb7c4e68604172bb2d81f01ac.webp",980,1306]